{
    "medicine_id": "58ee104f72305d08f346e91b98716d4c7346c364",
    "platform_id": "DB01049",
    "metadata": {
        "name": "Hydergine 1 mg 1 Tablet",
        "composition": "1 mg 1 Ergoloid mesylate",
        "clinical_particulars": {
            "therapeutic_indications": "It was labeled by the FDA for the treatment of symptoms of an idiopathic decline in the mental capacity not related to a potentially reversible condition A32913 as well as for age related cognitive impairment A32926 The prescription of this drug is conditioned to the corroboration that the patient is not suffering from a potentially reversible and treatable condition especially delirium and dementiform illness secondary to systemic disease primary neurological disease or primary mood disturbance L2637 To know more about the individual components of the ergoloid mixture please visit DB13345 and DB11274",
            "contraindications": {
                "disease": "Symptoms of overdose include dyspnea hypotension or hypertension rapid weak pulse delirium nausea vomiting and bradycardia The excessive use of ergoloid mesylate can lead to ergotism T90 To know more about the individual components of the ergoloid mixture please visit DB11274 DB11273 and DB13345",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "The mechanism of action of ergoloid mesylate is not completely established but it is thought that it increases both the blood flow and cerebral metabolism Some studies have shown a significant improvement in alertness and memory as well as a decline in confusion while some other benefits have shown a lack of effect A32913 Its action produces a damper in the impulses from the vasomotor center which reduces the vascular tone which translates in the slow of pulse rate prevention of compensatory tachycardia A32914 To know more about the individual components of the ergoloid mixture please visit DB11274 DB11273 and DB13345",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00177",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Valsartan"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Ramipril"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Torasemide"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Olmesartan"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Nitroprusside"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Prazosin"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Metolazone"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Benazepril"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Mecamylamine"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Perindopril"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Candesartan cilexetil"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Quinapril"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Telmisartan"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Hydrochlorothiazide"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Terazosin"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Captopril"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Epoprostenol"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Saprisartan"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Spirapril"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Temocapril"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Nicorandil"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Imidapril"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Delapril"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Candesartan"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Furosemide"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Enalapril"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Isradipine"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Diltiazem"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Amlodipine"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Nimodipine"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Nisoldipine"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Bosentan"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Losartan"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Indapamide"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Tadalafil"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Felodipine"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Irbesartan"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Nitrendipine"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Guanethidine"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Bepridil"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Hydralazine"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Mibefradil"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Riociguat"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Macitentan"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Niguldipine"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Selexipag"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Naftopidil"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Ergoloid mesylate may decrease the antihypertensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Buprenorphine"
                    },
                    {
                        "drugbank-id": "DB00366",
                        "description": "Doxylamine may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00450",
                        "description": "Droperidol may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "Hydrocodone may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00557",
                        "description": "Hydroxyzine may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be increased when used in combination with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB01403",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Methotrimeprazine"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Ergoloid mesylate may increase the sedative activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "Minocycline may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "Nabilone may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01173",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Orphenadrine"
                    },
                    {
                        "drugbank-id": "DB09117",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Paraldehyde"
                    },
                    {
                        "drugbank-id": "DB08883",
                        "description": "Perampanel may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may increase the sedative activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "Ropinirole may increase the sedative activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "Ergoloid mesylate may increase the sedative activities of Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The risk or severity of adverse effects can be increased when Rufinamide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB09072",
                        "description": "Sodium oxybate may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Suvorexant"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "Tapentadol may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB00425",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Zolpidem"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "The risk or severity of hypertension can be increased when Desmopressin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of hypertension can be increased when Icosapent is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of hypertension can be increased when Mesalazine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of hypertension can be increased when Indomethacin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "The risk or severity of hypertension can be increased when Methylphenidate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of hypertension can be increased when Nabumetone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of hypertension can be increased when Ketorolac is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of hypertension can be increased when Tenoxicam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of hypertension can be increased when Tolmetin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of hypertension can be increased when Piroxicam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00561",
                        "description": "The risk or severity of hypertension can be increased when Doxapram is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of hypertension can be increased when Fenoprofen is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of hypertension can be increased when Sulindac is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "The risk or severity of hypertension can be increased when Phentolamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The risk or severity of hypertension can be increased when Nicergoline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of hypertension can be increased when Flurbiprofen is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of hypertension can be increased when Etodolac is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of hypertension can be increased when Mefenamic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of hypertension can be increased when Naproxen is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of hypertension can be increased when Sulfasalazine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of hypertension can be increased when Tolazoline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of hypertension can be increased when Carprofen is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00830",
                        "description": "The risk or severity of hypertension can be increased when Phenmetrazine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of hypertension can be increased when Diflunisal is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hypertension can be increased when Omapatrilat is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of hypertension can be increased when Phenoxybenzamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of hypertension can be increased when Salicylic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "The risk or severity of hypertension can be increased when Dopamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of hypertension can be increased when Oxaprozin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of hypertension can be increased when Ketoprofen is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of hypertension can be increased when Balsalazide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Olsalazine"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Lumiracoxib"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Magnesium salicylate"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Salsalate"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Choline magnesium trisalicylate"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Antrafenine"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tiaprofenic acid"
                    },
                    {
                        "drugbank-id": "DB02032",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Epicaptopril"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Taxifolin"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Oxyphenbutazone"
                    },
                    {
                        "drugbank-id": "DB04581",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with 1 benzylimidazole"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Benoxaprofen"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Cimicoxib"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Lornoxicam"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Aceclofenac"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Zaltoprofen"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Saralasin"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Azapropazone"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Salicylamide"
                    },
                    {
                        "drugbank-id": "DB08841",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tyramine"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Kebuzone"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Isoxicam"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Indoramin"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Indoprofen"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Ibuproxam"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Floctafenine"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Fenbufen"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Etofenamate"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Epirizole"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Benzydamine"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Moxisylyte"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Dexibuprofen"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Dexketoprofen"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Droxicam"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Firocoxib"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Clonixin"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Morniflumate"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Talniflumate"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Robenacoxib"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11481",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Atipamezole"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Flunixin"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Nitroaspirin"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Indobufen"
                    },
                    {
                        "drugbank-id": "DB12551",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Idazoxan"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Ebselen"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tinoridine"
                    },
                    {
                        "drugbank-id": "DB13064",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tramazoline"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Alclofenac"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Fentiazac"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Suxibuzone"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Bumadizone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Alminoprofen"
                    },
                    {
                        "drugbank-id": "DB13341",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Fenozolone"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Difenpiramide"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Nifenazone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Lonazolac"
                    },
                    {
                        "drugbank-id": "DB13453",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Xenon"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tenidap"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Buflomedil"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Propyphenazone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Proglumetacin"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Guacetisal"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Ethenzamide"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Carbaspirin calcium"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Mofebutazone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Proquazone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Benorilate"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Pirprofen"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB13852",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Mefenorex"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Imidazole salicylate"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with SC 236"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with NS 398"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB01126",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Dutasteride"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of hypertension can be increased when Cyclosporine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of hypertension can be increased when Celecoxib is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of hypertension can be increased when Rofecoxib is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of hypertension can be increased when Valdecoxib is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of hypertension can be increased when Diclofenac is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of hypertension can be increased when Phenylbutazone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The risk or severity of hypertension can be increased when Meloxicam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Ibuprofen"
                    },
                    {
                        "drugbank-id": "DB01216",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Finasteride"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Aminophenazone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Antipyrine"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Etoricoxib"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Nimesulide"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Metamizole"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Zomepirac"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Parecoxib"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Tolfenamic acid"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Propacetamol"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Siponimod"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Dihydroergocristine"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Terguride"
                    },
                    {
                        "drugbank-id": "DB15685",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Selpercatinib"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Loxoprofen"
                    },
                    {
                        "drugbank-id": "DB15965",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Naxitamab"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "The risk or severity of adverse effects can be increased when Lorcaserin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The bioavailability of Ergoloid mesylate can be increased when combined with Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The risk or severity of adverse effects can be decreased when Cabergoline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The risk or severity of adverse effects can be decreased when Dihydroergotamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The risk or severity of adverse effects can be decreased when Lisuride is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The risk or severity of adverse effects can be decreased when Apomorphine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "The risk or severity of adverse effects can be decreased when Fenoldopam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Pergolide"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Bromocriptine"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Aripiprazole"
                    },
                    {
                        "drugbank-id": "DB09097",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Quinagolide"
                    },
                    {
                        "drugbank-id": "DB09128",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Brexpiprazole"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Dihydroergocornine"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Dopexamine"
                    },
                    {
                        "drugbank-id": "DB12478",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Piribedil"
                    },
                    {
                        "drugbank-id": "DB12890",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Dihydrexidine"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Dihydroergocryptine"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The risk or severity of adverse effects can be decreased when Ergoloid mesylate is combined with Metergoline"
                    },
                    {
                        "drugbank-id": "DB08873",
                        "description": "The risk or severity of adverse effects can be increased when Boceprevir is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Mifepristone"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The risk or severity of adverse effects can be increased when Methadone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of serotonin syndrome can be increased when Linezolid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dicoumarol"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenindione"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Coumarin"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tioclomarol"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Warfarin"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenprocoumon"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Acenocoumarol"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with 4 hydroxycoumarin"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with R warfarin"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ethyl biscoumacetate"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluindione"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clorindione"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Diphenadione"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with S Warfarin"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Clarithromycin"
                    },
                    {
                        "drugbank-id": "DB01263",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Posaconazole"
                    },
                    {
                        "drugbank-id": "DB00582",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Voriconazole"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tedizolid phosphate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00370",
                        "description": "Ergoloid mesylate may increase the serotonergic activities of Mirtazapine"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Cobicistat"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Ethanol"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Azelastine"
                    },
                    {
                        "drugbank-id": "DB00484",
                        "description": "Brimonidine may increase the central nervous system depressant CNS depressant activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluvoxamine"
                    },
                    {
                        "drugbank-id": "DB00215",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Citalopram"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB00715",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Paroxetine"
                    },
                    {
                        "drugbank-id": "DB01104",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Sertraline"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Sibutramine"
                    },
                    {
                        "drugbank-id": "DB04832",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zimelidine"
                    },
                    {
                        "drugbank-id": "DB04884",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dapoxetine"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Milnacipran"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Desvenlafaxine"
                    },
                    {
                        "drugbank-id": "DB06731",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Seproxetine"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Levomilnacipran"
                    },
                    {
                        "drugbank-id": "DB08953",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Indalpine"
                    },
                    {
                        "drugbank-id": "DB12693",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ritanserin"
                    },
                    {
                        "drugbank-id": "DB13233",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alaproclate"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "The risk or severity of adverse effects can be increased when Nefazodone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Midodrine"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Bethanidine"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Isoetharine"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Etomidate"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Norepinephrine"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Phenylephrine"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Phenylpropanolamine"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Metaraminol"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Guanabenz"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Dexmedetomidine"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Epinephrine"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Tizanidine"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Methoxamine"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Orciprenaline"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Dobutamine"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Ritodrine"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Terbutaline"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Bitolterol"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Oxymetazoline"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Formoterol"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Salbutamol"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Guanfacine"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Isoprenaline"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Arbutamine"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Ergometrine"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Arformoterol"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Fenoterol"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Pirbuterol"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Ephedra sinica root"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Ephedrine"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Procaterol"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Clenbuterol"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Bambuterol"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of 4 Methoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01537",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of 4 Bromo 2 5 dimethoxyphenethylamine"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Phendimetrazine"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Celiprolol"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Nebivolol"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Indacaterol"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Amibegron"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Nylidrin"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Solabegron"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Droxidopa"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Xylometazoline"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Isometheptene"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Levonordefrin"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Naphazoline"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Tetryzoline"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Protokylol"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Mirabegron"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Adrafinil"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Isoxsuprine"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Hexoprenaline"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Etilefrine"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Olodaterol"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Cirazoline"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Synephrine"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Moxonidine"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Doxofylline"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Racepinephrine"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of DL Methylephedrine"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Amitraz"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Medetomidine"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Xylazine"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Ractopamine"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Romifidine"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Detomidine"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Etafedrine"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Rilmenidine"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Anisodamine"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of PF 00610355"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Abediterol"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Tulobuterol"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Batefenterol"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Higenamine"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Reproterol"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Levosalbutamol"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Octopamine"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Norfenefrine"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Oxyfedrine"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Rimiterol"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Tretoquinol"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Prenalterol"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Xamoterol"
                    },
                    {
                        "drugbank-id": "DB14752",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Racephedrine"
                    },
                    {
                        "drugbank-id": "DB14547",
                        "description": "Ergoloid mesylate may increase the hypertensive and vasoconstricting activities of Chloride ion"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "Esmolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "Betaxolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "Sotalol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Propranolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Labetalol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Bisoprolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "Alprenolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Pindolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "Carvedilol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "Propafenone may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "Acebutolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Nadolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "Bevantolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "Practolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Penbutolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "Oxprenolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Dexpropranolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "Bufuralol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "Bopindolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "Bupranolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "Indenolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Arotinolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "Levobetaxolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "Talinolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "Bucindolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "Esatenolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "Cloranolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "Mepindolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "Epanolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "Tertatolol may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Landiolol"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Ergoloid mesylate may increase the serotonergic activities of Methylene blue"
                    },
                    {
                        "drugbank-id": "DB00209",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Trospium"
                    },
                    {
                        "drugbank-id": "DB00219",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Oxyphenonium"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Benzatropine"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB00332",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Ipratropium"
                    },
                    {
                        "drugbank-id": "DB00340",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Metixene"
                    },
                    {
                        "drugbank-id": "DB00354",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Buclizine"
                    },
                    {
                        "drugbank-id": "DB00376",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Trihexyphenidyl"
                    },
                    {
                        "drugbank-id": "DB00383",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Oxyphencyclimine"
                    },
                    {
                        "drugbank-id": "DB00387",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Procyclidine"
                    },
                    {
                        "drugbank-id": "DB00392",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Profenamine"
                    },
                    {
                        "drugbank-id": "DB00424",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Hyoscyamine"
                    },
                    {
                        "drugbank-id": "DB00462",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Methscopolamine bromide"
                    },
                    {
                        "drugbank-id": "DB00505",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Tridihexethyl"
                    },
                    {
                        "drugbank-id": "DB00517",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Anisotropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Atropine"
                    },
                    {
                        "drugbank-id": "DB00670",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Pirenzepine"
                    },
                    {
                        "drugbank-id": "DB00725",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Homatropine methylbromide"
                    },
                    {
                        "drugbank-id": "DB00767",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Benzquinamide"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Propantheline"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Dicyclomine"
                    },
                    {
                        "drugbank-id": "DB00810",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Biperiden"
                    },
                    {
                        "drugbank-id": "DB00940",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Methantheline"
                    },
                    {
                        "drugbank-id": "DB00942",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Cycrimine"
                    },
                    {
                        "drugbank-id": "DB00986",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Glycopyrronium"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Tolterodine"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Flavoxate"
                    },
                    {
                        "drugbank-id": "DB01231",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Diphenidol"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Tiotropium"
                    },
                    {
                        "drugbank-id": "DB01591",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Solifenacin"
                    },
                    {
                        "drugbank-id": "DB01625",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Isopropamide"
                    },
                    {
                        "drugbank-id": "DB04843",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Mepenzolate"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Fesoterodine"
                    },
                    {
                        "drugbank-id": "DB06787",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Hexocyclium"
                    },
                    {
                        "drugbank-id": "DB08801",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Dimetindene"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Aclidinium"
                    },
                    {
                        "drugbank-id": "DB08997",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Dexetimide"
                    },
                    {
                        "drugbank-id": "DB09076",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Umeclidinium"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Trimebutine"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Imidafenacin"
                    },
                    {
                        "drugbank-id": "DB09300",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Butylscopolamine"
                    },
                    {
                        "drugbank-id": "DB11235",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Thonzylamine"
                    },
                    {
                        "drugbank-id": "DB11315",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Methscopolamine"
                    },
                    {
                        "drugbank-id": "DB11855",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Revefenacin"
                    },
                    {
                        "drugbank-id": "DB12086",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Oxitropium"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Propiverine"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13252",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Tropatepine"
                    },
                    {
                        "drugbank-id": "DB13254",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Prifinium"
                    },
                    {
                        "drugbank-id": "DB13351",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Piperidolate"
                    },
                    {
                        "drugbank-id": "DB13369",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Benzilone"
                    },
                    {
                        "drugbank-id": "DB13380",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Difemerine"
                    },
                    {
                        "drugbank-id": "DB13413",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Phenglutarimide"
                    },
                    {
                        "drugbank-id": "DB13448",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Mazaticol"
                    },
                    {
                        "drugbank-id": "DB13468",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Etybenzatropine"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Otilonium"
                    },
                    {
                        "drugbank-id": "DB13507",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Poldine"
                    },
                    {
                        "drugbank-id": "DB13542",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Bevonium"
                    },
                    {
                        "drugbank-id": "DB13581",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Rociverine"
                    },
                    {
                        "drugbank-id": "DB13619",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Bornaprine"
                    },
                    {
                        "drugbank-id": "DB13636",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Etanautine"
                    },
                    {
                        "drugbank-id": "DB13666",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Tiemonium iodide"
                    },
                    {
                        "drugbank-id": "DB13678",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Dihexyverine"
                    },
                    {
                        "drugbank-id": "DB13695",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Penthienate"
                    },
                    {
                        "drugbank-id": "DB13720",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Diphemanil"
                    },
                    {
                        "drugbank-id": "DB13738",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Camylofin"
                    },
                    {
                        "drugbank-id": "DB13759",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Fenpiverinium"
                    },
                    {
                        "drugbank-id": "DB13769",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Emetonium iodide"
                    },
                    {
                        "drugbank-id": "DB13844",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Pipenzolate"
                    },
                    {
                        "drugbank-id": "DB13850",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Timepidium"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Nicardipine"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Amitriptyline"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Terfenadine"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Imipramine"
                    },
                    {
                        "drugbank-id": "DB00496",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Darifenacin"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Nortriptyline"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Quinidine"
                    },
                    {
                        "drugbank-id": "DB01062",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Oxybutynin"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Doxepin"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Quetiapine"
                    },
                    {
                        "drugbank-id": "DB09007",
                        "description": "Ergoloid mesylate may increase the central nervous system depressant CNS depressant activities of Chlorphenoxamine"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zopiclone"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Reserpine"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00680",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Moricizine"
                    },
                    {
                        "drugbank-id": "DB01246",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alimemazine"
                    },
                    {
                        "drugbank-id": "DB04872",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Osanetant"
                    },
                    {
                        "drugbank-id": "DB04888",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bifeprunox"
                    },
                    {
                        "drugbank-id": "DB05687",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with BL 1020"
                    },
                    {
                        "drugbank-id": "DB06077",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lumateperone"
                    },
                    {
                        "drugbank-id": "DB08927",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Amperozide"
                    },
                    {
                        "drugbank-id": "DB09000",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cyamemazine"
                    },
                    {
                        "drugbank-id": "DB09226",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Brilaroxazine"
                    },
                    {
                        "drugbank-id": "DB11540",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Propiopromazine"
                    },
                    {
                        "drugbank-id": "DB12401",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bromperidol"
                    },
                    {
                        "drugbank-id": "DB12958",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Prothipendyl"
                    },
                    {
                        "drugbank-id": "DB13213",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Butaperazine"
                    },
                    {
                        "drugbank-id": "DB13256",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clothiapine"
                    },
                    {
                        "drugbank-id": "DB13382",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Chlorproethazine"
                    },
                    {
                        "drugbank-id": "DB13403",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxypertine"
                    },
                    {
                        "drugbank-id": "DB13420",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Thiazinam"
                    },
                    {
                        "drugbank-id": "DB13523",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Veralipride"
                    },
                    {
                        "drugbank-id": "DB13554",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Moperone"
                    },
                    {
                        "drugbank-id": "DB13557",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Thiopropazate"
                    },
                    {
                        "drugbank-id": "DB13665",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluanisone"
                    },
                    {
                        "drugbank-id": "DB13676",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mosapramine"
                    },
                    {
                        "drugbank-id": "DB13784",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dixyrazine"
                    },
                    {
                        "drugbank-id": "DB14651",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Perphenazine enanthate"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lorpiprazole"
                    },
                    {
                        "drugbank-id": "DB00042",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum Toxin Type B is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00083",
                        "description": "The risk or severity of adverse effects can be increased when Botulinum toxin type A is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00150",
                        "description": "The risk or severity of adverse effects can be increased when Tryptophan is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of adverse effects can be increased when Baclofen is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The risk or severity of adverse effects can be increased when Lorazepam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00189",
                        "description": "The risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of adverse effects can be increased when Succinylcholine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The risk or severity of adverse effects can be increased when Enflurane is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "The risk or severity of adverse effects can be increased when Temazepam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00234",
                        "description": "The risk or severity of adverse effects can be increased when Reboxetine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "The risk or severity of adverse effects can be increased when Butabarbital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "The risk or severity of adverse effects can be increased when Butalbital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "The risk or severity of adverse effects can be increased when Topiramate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00283",
                        "description": "The risk or severity of adverse effects can be increased when Clemastine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "The risk or severity of adverse effects can be increased when Venlafaxine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "The risk or severity of adverse effects can be increased when Atomoxetine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The risk or severity of adverse effects can be increased when Morphine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00306",
                        "description": "The risk or severity of adverse effects can be increased when Talbutal is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "The risk or severity of adverse effects can be increased when Valproic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "The risk or severity of adverse effects can be increased when Codeine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "The risk or severity of adverse effects can be increased when Tolcapone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The risk or severity of adverse effects can be increased when Hydromorphone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "The risk or severity of adverse effects can be increased when Cetirizine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00344",
                        "description": "The risk or severity of adverse effects can be increased when Protriptyline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The risk or severity of adverse effects can be increased when Trimethadione is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "The risk or severity of adverse effects can be increased when Clobazam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The risk or severity of adverse effects can be increased when Chlorzoxazone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00371",
                        "description": "The risk or severity of adverse effects can be increased when Meprobamate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "The risk or severity of adverse effects can be increased when Palonosetron is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00405",
                        "description": "The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00408",
                        "description": "The risk or severity of adverse effects can be increased when Loxapine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "The risk or severity of adverse effects can be increased when Metocurine iodide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "The risk or severity of adverse effects can be increased when Secobarbital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00420",
                        "description": "The risk or severity of adverse effects can be increased when Promazine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00423",
                        "description": "The risk or severity of adverse effects can be increased when Methocarbamol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00427",
                        "description": "The risk or severity of adverse effects can be increased when Triprolidine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00434",
                        "description": "The risk or severity of adverse effects can be increased when Cyproheptadine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00463",
                        "description": "The risk or severity of adverse effects can be increased when Metharbital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The risk or severity of adverse effects can be increased when Quinine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "The risk or severity of adverse effects can be increased when Methohexital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00475",
                        "description": "The risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "The risk or severity of adverse effects can be increased when Gallamine triethiodide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00494",
                        "description": "The risk or severity of adverse effects can be increased when Entacapone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The risk or severity of adverse effects can be increased when Oxycodone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00514",
                        "description": "The risk or severity of adverse effects can be increased when Dextromethorphan is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The risk or severity of adverse effects can be increased when Mephenytoin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00543",
                        "description": "The risk or severity of adverse effects can be increased when Amoxapine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00546",
                        "description": "The risk or severity of adverse effects can be increased when Adinazolam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "The risk or severity of adverse effects can be increased when Lamotrigine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "The risk or severity of adverse effects can be increased when Cisatracurium is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00579",
                        "description": "The risk or severity of adverse effects can be increased when Mazindol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "The risk or severity of adverse effects can be increased when Thiopental is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The risk or severity of adverse effects can be increased when Butorphanol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "The risk or severity of adverse effects can be increased when Furazolidone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The risk or severity of adverse effects can be increased when Paramethadione is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "The risk or severity of adverse effects can be increased when Clorazepic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00645",
                        "description": "The risk or severity of adverse effects can be increased when Dyclonine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The risk or severity of adverse effects can be increased when Pentazocine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "The risk or severity of adverse effects can be increased when Metaxalone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00662",
                        "description": "The risk or severity of adverse effects can be increased when Trimethobenzamide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Thioridazine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "The risk or severity of adverse effects can be increased when Flurazepam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The risk or severity of adverse effects can be increased when Sufentanil is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "The risk or severity of adverse effects can be increased when Procaine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "The risk or severity of adverse effects can be increased when Rocuronium is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "The risk or severity of adverse effects can be increased when Atracurium besylate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "The risk or severity of adverse effects can be increased when Risperidone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00737",
                        "description": "The risk or severity of adverse effects can be increased when Meclizine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00740",
                        "description": "The risk or severity of adverse effects can be increased when Riluzole is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00747",
                        "description": "The risk or severity of adverse effects can be increased when Scopolamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00748",
                        "description": "The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Isoflurane is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00754",
                        "description": "The risk or severity of adverse effects can be increased when Ethotoin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00757",
                        "description": "The risk or severity of adverse effects can be increased when Dolasetron is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00771",
                        "description": "The risk or severity of adverse effects can be increased when Clidinium is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "The risk or severity of adverse effects can be increased when Phenelzine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00801",
                        "description": "The risk or severity of adverse effects can be increased when Halazepam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "The risk or severity of adverse effects can be increased when Minaprine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of adverse effects can be increased when Propofol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00819",
                        "description": "The risk or severity of adverse effects can be increased when Acetazolamide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "The risk or severity of adverse effects can be increased when Diazepam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00832",
                        "description": "The risk or severity of adverse effects can be increased when Phensuximide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00835",
                        "description": "The risk or severity of adverse effects can be increased when Brompheniramine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00837",
                        "description": "The risk or severity of adverse effects can be increased when Progabide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "The risk or severity of adverse effects can be increased when Oxazepam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00843",
                        "description": "The risk or severity of adverse effects can be increased when Donepezil is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The risk or severity of adverse effects can be increased when Nalbuphine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "The risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The risk or severity of adverse effects can be increased when Levorphanol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00875",
                        "description": "The risk or severity of adverse effects can be increased when Flupentixol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00889",
                        "description": "The risk or severity of adverse effects can be increased when Granisetron is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The risk or severity of adverse effects can be increased when Remifentanil is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00904",
                        "description": "The risk or severity of adverse effects can be increased when Ondansetron is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00906",
                        "description": "The risk or severity of adverse effects can be increased when Tiagabine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "The risk or severity of adverse effects can be increased when Zonisamide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "The risk or severity of adverse effects can be increased when Maprotiline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00941",
                        "description": "The risk or severity of adverse effects can be increased when Hexafluronium is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The risk or severity of adverse effects can be increased when Felbamate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "The risk or severity of adverse effects can be increased when Zaleplon is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00967",
                        "description": "The risk or severity of adverse effects can be increased when Desloratadine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00969",
                        "description": "The risk or severity of adverse effects can be increased when Alosetron is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "The risk or severity of adverse effects can be increased when Ramelteon is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00985",
                        "description": "The risk or severity of adverse effects can be increased when Dimenhydrinate is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00996",
                        "description": "The risk or severity of adverse effects can be increased when Gabapentin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The risk or severity of adverse effects can be increased when Methoxyflurane is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "The risk or severity of adverse effects can be increased when Selegiline is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01065",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Melatonin"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clonazepam"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Promethazine"
                    },
                    {
                        "drugbank-id": "DB01075",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Diphenhydramine"
                    },
                    {
                        "drugbank-id": "DB01080",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vigabatrin"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01107",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Methyprylon"
                    },
                    {
                        "drugbank-id": "DB01114",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Chlorpheniramine"
                    },
                    {
                        "drugbank-id": "DB01121",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenacemide"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Desipramine"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Thiamylal"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bupropion"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Moclobemide"
                    },
                    {
                        "drugbank-id": "DB01176",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cyclizine"
                    },
                    {
                        "drugbank-id": "DB01178",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Chlormezanone"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01202",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Levetiracetam"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Estazolam"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ketamine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01245",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Decamethonium"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Isocarboxazid"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Paliperidone"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vecuronium"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Amobarbital"
                    },
                    {
                        "drugbank-id": "DB01352",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Aprobarbital"
                    },
                    {
                        "drugbank-id": "DB01353",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Butobarbital"
                    },
                    {
                        "drugbank-id": "DB01354",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Heptabarbital"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Hexobarbital"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lithium cation"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rasagiline"
                    },
                    {
                        "drugbank-id": "DB01392",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Yohimbine"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01437",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Glutethimide"
                    },
                    {
                        "drugbank-id": "DB01440",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with gamma Hydroxybutyric acid"
                    },
                    {
                        "drugbank-id": "DB01445",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bufotenine"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01463",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fencamfamin"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Barbital"
                    },
                    {
                        "drugbank-id": "DB01488",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB01489",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Camazepam"
                    },
                    {
                        "drugbank-id": "DB01495",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dichloralphenazone"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01501",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Difenoxin"
                    },
                    {
                        "drugbank-id": "DB01511",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Delorazepam"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01534",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Chlorhexadol"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01544",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Flunitrazepam"
                    },
                    {
                        "drugbank-id": "DB01545",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ethyl loflazepate"
                    },
                    {
                        "drugbank-id": "DB01547",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Drotebanol"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01553",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cloxazolam"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bromazepam"
                    },
                    {
                        "drugbank-id": "DB01559",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clotiazepam"
                    },
                    {
                        "drugbank-id": "DB01560",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cathinone"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB01567",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fludiazepam"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ketazolam"
                    },
                    {
                        "drugbank-id": "DB01588",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Prazepam"
                    },
                    {
                        "drugbank-id": "DB01589",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Quazepam"
                    },
                    {
                        "drugbank-id": "DB01594",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cinolazepam"
                    },
                    {
                        "drugbank-id": "DB01595",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nitrazepam"
                    },
                    {
                        "drugbank-id": "DB01616",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alverine"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zuclopenthixol"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pargyline"
                    },
                    {
                        "drugbank-id": "DB01954",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rolipram"
                    },
                    {
                        "drugbank-id": "DB02207",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with 7 Nitroindazole"
                    },
                    {
                        "drugbank-id": "DB02234",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with S Ethylisothiourea"
                    },
                    {
                        "drugbank-id": "DB02852",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Domoic Acid"
                    },
                    {
                        "drugbank-id": "DB02959",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxitriptan"
                    },
                    {
                        "drugbank-id": "DB03575",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phencyclidine"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clorgiline"
                    },
                    {
                        "drugbank-id": "DB04165",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Valpromide"
                    },
                    {
                        "drugbank-id": "DB04325",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenethylamine"
                    },
                    {
                        "drugbank-id": "DB04599",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Aniracetam"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iproniazid"
                    },
                    {
                        "drugbank-id": "DB04819",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Methapyrilene"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nialamide"
                    },
                    {
                        "drugbank-id": "DB04821",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nomifensine"
                    },
                    {
                        "drugbank-id": "DB04827",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Urethane"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lysergic acid diethylamide"
                    },
                    {
                        "drugbank-id": "DB04833",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Methaqualone"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB04836",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Amineptine"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB04885",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cilansetron"
                    },
                    {
                        "drugbank-id": "DB04903",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pagoclone"
                    },
                    {
                        "drugbank-id": "DB04917",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Renzapride"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iloperidone"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ezogabine"
                    },
                    {
                        "drugbank-id": "DB05227",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with APD791"
                    },
                    {
                        "drugbank-id": "DB05232",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tetrodotoxin"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05316",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pimavanserin"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Brivaracetam"
                    },
                    {
                        "drugbank-id": "DB05542",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Naronapride"
                    },
                    {
                        "drugbank-id": "DB05607",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with PRX 08066"
                    },
                    {
                        "drugbank-id": "DB05710",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Gantacurium"
                    },
                    {
                        "drugbank-id": "DB06109",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with YKP 1358"
                    },
                    {
                        "drugbank-id": "DB06144",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Sertindole"
                    },
                    {
                        "drugbank-id": "DB06148",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mianserin"
                    },
                    {
                        "drugbank-id": "DB06153",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pizotifen"
                    },
                    {
                        "drugbank-id": "DB06216",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Asenapine"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lacosamide"
                    },
                    {
                        "drugbank-id": "DB06264",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tolperisone"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Levocetirizine"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06458",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Remacemide"
                    },
                    {
                        "drugbank-id": "DB06470",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clomethiazole"
                    },
                    {
                        "drugbank-id": "DB06512",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Deramciclane"
                    },
                    {
                        "drugbank-id": "DB06527",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tramiprosate"
                    },
                    {
                        "drugbank-id": "DB06529",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ocinaplon"
                    },
                    {
                        "drugbank-id": "DB06554",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Gaboxadol"
                    },
                    {
                        "drugbank-id": "DB06579",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Adipiplon"
                    },
                    {
                        "drugbank-id": "DB06582",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dextofisopam"
                    },
                    {
                        "drugbank-id": "DB06594",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Agomelatine"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Safinamide"
                    },
                    {
                        "drugbank-id": "DB06660",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Saredutant"
                    },
                    {
                        "drugbank-id": "DB06678",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Esmirtazapine"
                    },
                    {
                        "drugbank-id": "DB06690",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nitrous oxide"
                    },
                    {
                        "drugbank-id": "DB06691",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mepyramine"
                    },
                    {
                        "drugbank-id": "DB06701",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dexmethylphenidate"
                    },
                    {
                        "drugbank-id": "DB06716",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fospropofol"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ketobemidone"
                    },
                    {
                        "drugbank-id": "DB06753",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Triclofos"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Benzyl alcohol"
                    },
                    {
                        "drugbank-id": "DB06797",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mebutamate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08329",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Sulthiame"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with 7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline"
                    },
                    {
                        "drugbank-id": "DB08811",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tofisopam"
                    },
                    {
                        "drugbank-id": "DB08839",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Serotonin"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with DPDPE"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Gabapentin enacarbil"
                    },
                    {
                        "drugbank-id": "DB08892",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Arbaclofen Placarbil"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB08954",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ifenprodil"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB08986",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Etifoxine"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dimetacrine"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Barbexaclone"
                    },
                    {
                        "drugbank-id": "DB09011",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Beclamide"
                    },
                    {
                        "drugbank-id": "DB09014",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Captodiame"
                    },
                    {
                        "drugbank-id": "DB09016",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Butriptyline"
                    },
                    {
                        "drugbank-id": "DB09017",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Brotizolam"
                    },
                    {
                        "drugbank-id": "DB09021",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Benzoctamine"
                    },
                    {
                        "drugbank-id": "DB09023",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Benactyzine"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tasimelteon"
                    },
                    {
                        "drugbank-id": "DB09119",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Eslicarbazepine acetate"
                    },
                    {
                        "drugbank-id": "DB09166",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Etizolam"
                    },
                    {
                        "drugbank-id": "DB09167",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dosulepin"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09184",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Edivoxetine"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Viloxazine"
                    },
                    {
                        "drugbank-id": "DB09186",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nisoxetine"
                    },
                    {
                        "drugbank-id": "DB09187",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lortalamine"
                    },
                    {
                        "drugbank-id": "DB09190",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Talopram"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Etoperidone"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Blonanserin"
                    },
                    {
                        "drugbank-id": "DB09225",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zotepine"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Hydracarbazine"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pirlindole"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Toloxatone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Benmoxin"
                    },
                    {
                        "drugbank-id": "DB09247",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iproclozide"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mebanazine"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Octamoxin"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pheniprazine"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenoxypropazine"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pivhydrazine"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Safrazine"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Caroxazone"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB09290",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ramosetron"
                    },
                    {
                        "drugbank-id": "DB09307",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxaprotiline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Opium"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pyrantel"
                    },
                    {
                        "drugbank-id": "DB11371",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alfaxalone"
                    },
                    {
                        "drugbank-id": "DB11549",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tiletamine"
                    },
                    {
                        "drugbank-id": "DB11552",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tricaine"
                    },
                    {
                        "drugbank-id": "DB11555",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Zolazepam"
                    },
                    {
                        "drugbank-id": "DB11582",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Thiocolchicoside"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Normethadone"
                    },
                    {
                        "drugbank-id": "DB11664",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Psilocybin"
                    },
                    {
                        "drugbank-id": "DB11675",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mosapride"
                    },
                    {
                        "drugbank-id": "DB11686",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iferanserin"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tropisetron"
                    },
                    {
                        "drugbank-id": "DB11859",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Brexanolone"
                    },
                    {
                        "drugbank-id": "DB11868",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Etiracetam"
                    },
                    {
                        "drugbank-id": "DB11889",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lanicemine"
                    },
                    {
                        "drugbank-id": "DB11957",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Idalopirdine"
                    },
                    {
                        "drugbank-id": "DB12071",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vabicaserin"
                    },
                    {
                        "drugbank-id": "DB12105",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Imagabalin"
                    },
                    {
                        "drugbank-id": "DB12110",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with m Chlorophenylpiperazine"
                    },
                    {
                        "drugbank-id": "DB12111",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with MK 212"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Sarpogrelate"
                    },
                    {
                        "drugbank-id": "DB12177",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Eplivanserin"
                    },
                    {
                        "drugbank-id": "DB12184",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Gepirone"
                    },
                    {
                        "drugbank-id": "DB12229",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cerlapirdine"
                    },
                    {
                        "drugbank-id": "DB12308",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Eltanolone"
                    },
                    {
                        "drugbank-id": "DB12327",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Salvinorin A"
                    },
                    {
                        "drugbank-id": "DB12338",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Carisbamate"
                    },
                    {
                        "drugbank-id": "DB12395",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Esreboxetine"
                    },
                    {
                        "drugbank-id": "DB12427",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Orvepitant"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Piritramide"
                    },
                    {
                        "drugbank-id": "DB12537",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Benzodiazepine"
                    },
                    {
                        "drugbank-id": "DB12576",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with AZD 3043"
                    },
                    {
                        "drugbank-id": "DB12590",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Indiplon"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Urapidil"
                    },
                    {
                        "drugbank-id": "DB12725",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with TD 8954"
                    },
                    {
                        "drugbank-id": "DB12833",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tandospirone"
                    },
                    {
                        "drugbank-id": "DB12883",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Eltoprazine"
                    },
                    {
                        "drugbank-id": "DB12930",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Opipramol"
                    },
                    {
                        "drugbank-id": "DB12951",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pivagabine"
                    },
                    {
                        "drugbank-id": "DB12989",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Neosaxitoxin"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13082",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nefiracetam"
                    },
                    {
                        "drugbank-id": "DB13099",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Valnoctamide"
                    },
                    {
                        "drugbank-id": "DB13114",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Amitriptylinoxide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13219",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Medifoxamine"
                    },
                    {
                        "drugbank-id": "DB13221",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Apronalide"
                    },
                    {
                        "drugbank-id": "DB13225",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Dibenzepin"
                    },
                    {
                        "drugbank-id": "DB13234",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Propanidid"
                    },
                    {
                        "drugbank-id": "DB13246",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Quinupramine"
                    },
                    {
                        "drugbank-id": "DB13253",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Proxibarbal"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Atracurium"
                    },
                    {
                        "drugbank-id": "DB13303",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Febarbamate"
                    },
                    {
                        "drugbank-id": "DB13323",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Trichloroethylene"
                    },
                    {
                        "drugbank-id": "DB13324",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tetrazepam"
                    },
                    {
                        "drugbank-id": "DB13331",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pyrithyldione"
                    },
                    {
                        "drugbank-id": "DB13335",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pinazepam"
                    },
                    {
                        "drugbank-id": "DB13352",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Deanol"
                    },
                    {
                        "drugbank-id": "DB13354",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenprobamate"
                    },
                    {
                        "drugbank-id": "DB13357",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Styramate"
                    },
                    {
                        "drugbank-id": "DB13362",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pheneturide"
                    },
                    {
                        "drugbank-id": "DB13370",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bromisoval"
                    },
                    {
                        "drugbank-id": "DB13377",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vinbarbital"
                    },
                    {
                        "drugbank-id": "DB13384",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Melitracen"
                    },
                    {
                        "drugbank-id": "DB13396",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Neocitrullamon"
                    },
                    {
                        "drugbank-id": "DB13402",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Acetylglycinamide chloral hydrate"
                    },
                    {
                        "drugbank-id": "DB13411",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lofepramine"
                    },
                    {
                        "drugbank-id": "DB13414",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fenyramidol"
                    },
                    {
                        "drugbank-id": "DB13437",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Medazepam"
                    },
                    {
                        "drugbank-id": "DB13455",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenibut"
                    },
                    {
                        "drugbank-id": "DB13457",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxaflozane"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13496",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iprindole"
                    },
                    {
                        "drugbank-id": "DB13505",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Emepronium"
                    },
                    {
                        "drugbank-id": "DB13522",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mebicar"
                    },
                    {
                        "drugbank-id": "DB13534",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Gedocarnil"
                    },
                    {
                        "drugbank-id": "DB13541",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Iprazochrome"
                    },
                    {
                        "drugbank-id": "DB13550",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bifemelane"
                    },
                    {
                        "drugbank-id": "DB13572",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Emylcamate"
                    },
                    {
                        "drugbank-id": "DB13577",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Allobarbital"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Gallamine"
                    },
                    {
                        "drugbank-id": "DB13588",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Naftidrofuryl"
                    },
                    {
                        "drugbank-id": "DB13598",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Diethyl ether"
                    },
                    {
                        "drugbank-id": "DB13601",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxiracetam"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13623",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fabomotizole"
                    },
                    {
                        "drugbank-id": "DB13642",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pridinol"
                    },
                    {
                        "drugbank-id": "DB13643",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Loprazolam"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Alcuronium"
                    },
                    {
                        "drugbank-id": "DB13662",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Hexapropymate"
                    },
                    {
                        "drugbank-id": "DB13687",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Niaprazine"
                    },
                    {
                        "drugbank-id": "DB13690",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vinyl ether"
                    },
                    {
                        "drugbank-id": "DB13733",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Methylpentynol"
                    },
                    {
                        "drugbank-id": "DB13737",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cyclobarbital"
                    },
                    {
                        "drugbank-id": "DB13745",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fazadinium bromide"
                    },
                    {
                        "drugbank-id": "DB13754",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Mephenoxalone"
                    },
                    {
                        "drugbank-id": "DB13770",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Vinylbital"
                    },
                    {
                        "drugbank-id": "DB13782",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Imipramine oxide"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tilidine"
                    },
                    {
                        "drugbank-id": "DB13799",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ethadione"
                    },
                    {
                        "drugbank-id": "DB13805",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Reposal"
                    },
                    {
                        "drugbank-id": "DB13817",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Carbromal"
                    },
                    {
                        "drugbank-id": "DB13837",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Doxefazepam"
                    },
                    {
                        "drugbank-id": "DB13872",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lormetazepam"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Harmaline"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Brofaromine"
                    },
                    {
                        "drugbank-id": "DB13948",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with N 2 hydroxybenzyl 2 5 dimethoxy 4 cyanophenylethylamine"
                    },
                    {
                        "drugbank-id": "DB13984",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cyclopropane"
                    },
                    {
                        "drugbank-id": "DB13993",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with MRK 409"
                    },
                    {
                        "drugbank-id": "DB14028",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Nordazepam"
                    },
                    {
                        "drugbank-id": "DB14050",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cannabidivarin"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Aripiprazole lauroxil"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lithium carbonate"
                    },
                    {
                        "drugbank-id": "DB14575",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Eslicarbazepine"
                    },
                    {
                        "drugbank-id": "DB14672",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Oxazepam acetate"
                    },
                    {
                        "drugbank-id": "DB14715",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Cinazepam"
                    },
                    {
                        "drugbank-id": "DB14718",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pyrazolam"
                    },
                    {
                        "drugbank-id": "DB14719",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Bentazepam"
                    },
                    {
                        "drugbank-id": "DB15203",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with JNJ 26489112"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB00726",
                        "description": "The risk or severity of adverse effects can be increased when Trimipramine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The risk or severity of adverse effects can be increased when Methysergide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of adverse effects can be increased when Phenytoin is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "The risk or severity of adverse effects can be increased when Pentobarbital is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The risk or severity of adverse effects can be increased when Alprazolam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The risk or severity of adverse effects can be increased when Meperidine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of adverse effects can be increased when Ethosuximide is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The risk or severity of adverse effects can be increased when Cisapride is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "The risk or severity of adverse effects can be increased when Efavirenz is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The risk or severity of adverse effects can be increased when Midazolam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00776",
                        "description": "The risk or severity of adverse effects can be increased when Oxcarbazepine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The risk or severity of adverse effects can be increased when Primidone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The risk or severity of adverse effects can be increased when Alfentanil is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The risk or severity of adverse effects can be increased when Fentanyl is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of adverse effects can be increased when Triazolam is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Phenobarbital"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Clomipramine"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Fosphenytoin"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with St John s Wort"
                    },
                    {
                        "drugbank-id": "DB08815",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lurasidone"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Stiripentol"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB11951",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Lemborexant"
                    },
                    {
                        "drugbank-id": "DB12404",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Remimazolam"
                    },
                    {
                        "drugbank-id": "DB00751",
                        "description": "The risk or severity of adverse effects can be increased when Epinastine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00315",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Zolmitriptan"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Sumatriptan"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Almotriptan"
                    },
                    {
                        "drugbank-id": "DB00952",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Naratriptan"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Rizatriptan"
                    },
                    {
                        "drugbank-id": "DB00998",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Frovatriptan"
                    },
                    {
                        "drugbank-id": "DB04908",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Flibanserin"
                    },
                    {
                        "drugbank-id": "DB05562",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Naluzotan"
                    },
                    {
                        "drugbank-id": "DB06016",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Cariprazine"
                    },
                    {
                        "drugbank-id": "DB06684",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Vilazodone"
                    },
                    {
                        "drugbank-id": "DB08810",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Cinitapride"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Vortioxetine"
                    },
                    {
                        "drugbank-id": "DB11755",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Tetrahydrocannabivarin"
                    },
                    {
                        "drugbank-id": "DB12361",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of Piclozotan"
                    },
                    {
                        "drugbank-id": "DB14010",
                        "description": "Ergoloid mesylate may increase the vasoconstricting activities of 5 methoxy N N dimethyltryptamine"
                    },
                    {
                        "drugbank-id": "DB00216",
                        "description": "Eletriptan may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "Ergotamine may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Azithromycin"
                    },
                    {
                        "drugbank-id": "DB00954",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Dirithromycin"
                    },
                    {
                        "drugbank-id": "DB01152",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Candicidin"
                    },
                    {
                        "drugbank-id": "DB01321",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Josamycin"
                    },
                    {
                        "drugbank-id": "DB01873",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Epothilone D"
                    },
                    {
                        "drugbank-id": "DB03010",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Patupilone"
                    },
                    {
                        "drugbank-id": "DB04070",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with 6 Deoxyerythronolide B"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB05903",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with KOS 1584"
                    },
                    {
                        "drugbank-id": "DB06233",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Ridaforolimus"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06587",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Mitemcinal"
                    },
                    {
                        "drugbank-id": "DB07348",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Brefeldin A"
                    },
                    {
                        "drugbank-id": "DB09308",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Solithromycin"
                    },
                    {
                        "drugbank-id": "DB09309",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Kitasamycin"
                    },
                    {
                        "drugbank-id": "DB11383",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Carbomycin"
                    },
                    {
                        "drugbank-id": "DB11400",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Doramectin"
                    },
                    {
                        "drugbank-id": "DB11405",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Eprinomectin"
                    },
                    {
                        "drugbank-id": "DB11442",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Oleandomycin"
                    },
                    {
                        "drugbank-id": "DB11459",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Selamectin"
                    },
                    {
                        "drugbank-id": "DB11470",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Tildipirosin"
                    },
                    {
                        "drugbank-id": "DB11471",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Tilmicosin"
                    },
                    {
                        "drugbank-id": "DB11475",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Tylosin"
                    },
                    {
                        "drugbank-id": "DB11554",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Tylvalosin"
                    },
                    {
                        "drugbank-id": "DB11752",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Bryostatin 1"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12266",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Epofolate"
                    },
                    {
                        "drugbank-id": "DB12391",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Sagopilone"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB13179",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Troleandomycin"
                    },
                    {
                        "drugbank-id": "DB13287",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Miocamycin"
                    },
                    {
                        "drugbank-id": "DB13338",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Flurithromycin"
                    },
                    {
                        "drugbank-id": "DB13409",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Rokitamycin"
                    },
                    {
                        "drugbank-id": "DB13456",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Midecamycin"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Sirolimus"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Everolimus"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB01190",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Clindamycin"
                    },
                    {
                        "drugbank-id": "DB13633",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Mepartricin"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be increased when used in combination with Pregabalin"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "The serum concentration of Ergoloid mesylate can be decreased when it is combined with Pitolisant"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be increased when used in combination with Lofexidine"
                    },
                    {
                        "drugbank-id": "DB09046",
                        "description": "The metabolism of Ergoloid mesylate can be increased when combined with Metreleptin"
                    },
                    {
                        "drugbank-id": "DB05077",
                        "description": "The risk or severity of adverse effects can be increased when SLV319 is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB06155",
                        "description": "The risk or severity of adverse effects can be increased when Rimonabant is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB06624",
                        "description": "The risk or severity of adverse effects can be increased when Taranabant is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "The risk or severity of adverse effects can be increased when Cannabidiol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB11903",
                        "description": "The risk or severity of adverse effects can be increased when GW842166 is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB12193",
                        "description": "The risk or severity of adverse effects can be increased when Ajulemic acid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB12649",
                        "description": "The risk or severity of adverse effects can be increased when Ibipinabant is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13070",
                        "description": "The risk or severity of adverse effects can be increased when Surinabant is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of adverse effects can be increased when WIN 55212 2 is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "The risk or severity of adverse effects can be increased when Nabiximols is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB14043",
                        "description": "The risk or severity of adverse effects can be increased when Palmidrol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB14737",
                        "description": "The risk or severity of adverse effects can be increased when Cannabinol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of serotonin syndrome can be increased when Naltrexone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00907",
                        "description": "The risk or severity of serotonin syndrome can be increased when Cocaine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "The risk or severity of serotonin syndrome can be increased when Amantadine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of serotonin syndrome can be increased when Isoniazid is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01191",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Dexfenfluramine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB08167",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Methylthioninium"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13910",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Valproate bismuth"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The risk or severity of serotonin syndrome can be increased when Buspirone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Gilteritinib"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "Ergoloid mesylate may decrease the hypertensive activities of Theodrenaline"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "Ergoloid mesylate may decrease the hypertensive activities of Deoxyepinephrine"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Methylergometrine"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Thiethylperazine"
                    },
                    {
                        "drugbank-id": "DB00391",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Sulpiride"
                    },
                    {
                        "drugbank-id": "DB00409",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Remoxipride"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Prochlorperazine"
                    },
                    {
                        "drugbank-id": "DB00508",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Triflupromazine"
                    },
                    {
                        "drugbank-id": "DB00623",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Fluphenazine"
                    },
                    {
                        "drugbank-id": "DB00777",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Propiomazine"
                    },
                    {
                        "drugbank-id": "DB00831",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Trifluoperazine"
                    },
                    {
                        "drugbank-id": "DB00850",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Perphenazine"
                    },
                    {
                        "drugbank-id": "DB00933",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Mesoridazine"
                    },
                    {
                        "drugbank-id": "DB01038",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Carphenazine"
                    },
                    {
                        "drugbank-id": "DB01063",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Acetophenazine"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Domperidone"
                    },
                    {
                        "drugbank-id": "DB01239",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Chlorprothixene"
                    },
                    {
                        "drugbank-id": "DB01425",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Alizapride"
                    },
                    {
                        "drugbank-id": "DB01608",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Periciazine"
                    },
                    {
                        "drugbank-id": "DB01614",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Acepromazine"
                    },
                    {
                        "drugbank-id": "DB01615",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Aceprometazine"
                    },
                    {
                        "drugbank-id": "DB01618",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Molindone"
                    },
                    {
                        "drugbank-id": "DB01621",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Pipotiazine"
                    },
                    {
                        "drugbank-id": "DB01622",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Thioproperazine"
                    },
                    {
                        "drugbank-id": "DB01623",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Thiothixene"
                    },
                    {
                        "drugbank-id": "DB06288",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Amisulpride"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Perospirone"
                    },
                    {
                        "drugbank-id": "DB09018",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Bromopride"
                    },
                    {
                        "drugbank-id": "DB09207",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with AS 8112"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Melperone"
                    },
                    {
                        "drugbank-id": "DB11376",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Azaperone"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12273",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Ecopipam"
                    },
                    {
                        "drugbank-id": "DB12518",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Raclopride"
                    },
                    {
                        "drugbank-id": "DB12579",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with JNJ 37822681"
                    },
                    {
                        "drugbank-id": "DB12710",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Perazine"
                    },
                    {
                        "drugbank-id": "DB12867",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Benperidol"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Tiapride"
                    },
                    {
                        "drugbank-id": "DB13273",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Sultopride"
                    },
                    {
                        "drugbank-id": "DB13511",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Clebopride"
                    },
                    {
                        "drugbank-id": "DB13552",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Trifluperidol"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13841",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Clopenthixol"
                    },
                    {
                        "drugbank-id": "DB15167",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Fallypride"
                    },
                    {
                        "drugbank-id": "DB15492",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Eticlopride"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Amphetamine"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Phentermine"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Pseudoephedrine"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Benzphetamine"
                    },
                    {
                        "drugbank-id": "DB00937",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Diethylpropion"
                    },
                    {
                        "drugbank-id": "DB01255",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Lisdexamfetamine"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Mephentermine"
                    },
                    {
                        "drugbank-id": "DB01442",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with MMDA"
                    },
                    {
                        "drugbank-id": "DB01454",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Midomafetamine"
                    },
                    {
                        "drugbank-id": "DB01467",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with 2 5 Dimethoxy 4 ethylamphetamine"
                    },
                    {
                        "drugbank-id": "DB01484",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with 4 Bromo 2 5 dimethoxyamphetamine"
                    },
                    {
                        "drugbank-id": "DB01509",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Tenamfetamine"
                    },
                    {
                        "drugbank-id": "DB01556",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Chlorphentermine"
                    },
                    {
                        "drugbank-id": "DB01566",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Methylenedioxyethamphetamine"
                    },
                    {
                        "drugbank-id": "DB01576",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Dextroamphetamine"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Metamfetamine"
                    },
                    {
                        "drugbank-id": "DB09480",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Iofetamine I 123"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Ritobegron"
                    },
                    {
                        "drugbank-id": "DB13108",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Mephedrone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Methoxyphenamine"
                    },
                    {
                        "drugbank-id": "DB13703",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with Gepefrine"
                    },
                    {
                        "drugbank-id": "DB13940",
                        "description": "The therapeutic efficacy of Ergoloid mesylate can be decreased when used in combination with 2 5 Dimethoxy 4 ethylthioamphetamine"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "Erythromycin may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00778",
                        "description": "Roxithromycin may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00976",
                        "description": "Telithromycin may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB06419",
                        "description": "Cethromycin may increase the vasoconstricting activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB11823",
                        "description": "The risk or severity of hypertension can be increased when Esketamine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00395",
                        "description": "The risk or severity of adverse effects can be increased when Carisoprodol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "The risk or severity of hypertension can be increased when Solriamfetol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "Testosterone undecanoate may increase the hypertensive activities of Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00281",
                        "description": "The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Lidocaine"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The risk or severity of CNS depression can be increased when Ergoloid mesylate is combined with Eszopiclone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The risk or severity of sedation can be increased when Clonidine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00656",
                        "description": "The risk or severity of serotonin syndrome can be increased when Trazodone is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00924",
                        "description": "The risk or severity of CNS depression can be increased when Ergoloid mesylate is combined with Cyclobenzaprine"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of sedation can be increased when Ergoloid mesylate is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01175",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Escitalopram"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The serum concentration of Ergoloid mesylate can be decreased when it is combined with Cenobamate"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The risk or severity of serotonin syndrome can be increased when Tramadol is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Ergoloid mesylate may increase the vasodilatory activities of Isosorbide mononitrate"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Ziprasidone"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Ritonavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The risk or severity of CNS depression can be increased when Ergoloid mesylate is combined with Haloperidol"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB00472",
                        "description": "The risk or severity of serotonin syndrome can be increased when Ergoloid mesylate is combined with Fluoxetine"
                    },
                    {
                        "drugbank-id": "DB00574",
                        "description": "The risk or severity of serotonin syndrome can be increased when Fenfluramine is combined with Ergoloid mesylate"
                    },
                    {
                        "drugbank-id": "DB11932",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with Abametapir"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The risk or severity of hypotension sedation death somnolence and respiratory depression can be increased when Ergoloid mesylate is combined with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB15762",
                        "description": "The serum concentration of Ergoloid mesylate can be decreased when it is combined with Satralizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}